Pentacel DTaP-IPV-Hib
Selected indexed studies
- DTaP-IPV/Hib vaccine (Pentacel). (Paediatr Drugs, 2008) [PMID:18998751]
- New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). (Ann Pharmacother, 2010) [PMID:20197476]
- Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants. (Hum Vaccin Immunother, 2021) [PMID:32750261]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose. (2015) pubmed
- New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). (2010) pubmed
- Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix or Pentacel? (2010) pubmed
- DTaP-IPV/Hib vaccine (Pentacel). (2008) pubmed
- Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants. (2021) pubmed
- Pediatric combined formulation DTaP-IPV/Hib vaccine. (2009) pubmed
- Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL and ADACEL. (2006) pubmed
- Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers. (2006) pubmed
- Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants. (2017) pubmed
- Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age. (2007) pubmed